Combined use of an improved nucleofection technology and growth factors for pre-clinic therapeutic neovascularization research

Ziyang Zhang, Alex Slobodianski, Wulf Ito, Astrid Kathöfer, Jessica Frenz, Shaoxiang Weng, Natalie Lund, J.Tomas Egana & Hans-Günther Machens
Introduction: Induction of neovascularization by releasing of therapeutic growth factors can be achieved by using gene modified cells. This is a promising application of gene therapy to treat several ischemic related problems. In order to succeed in clinical translation, new experimental approaches [for full text, please go to the a.m. URL]